Market Cap 880.05M
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 2,749,900
Avg Vol 4,186,004
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 38%
Beta 0.81
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
Rastafari
Rastafari Feb. 14 at 4:43 PM
$ABCL These reflect institutions that have reported new positions or significant increases in ABCL stock in the latest reporting periods (e.g., Q3 2025 – recent 13F filings): • State of Michigan Retirement System – significantly boosted its stake, reporting ~400,000 shares after adding ~350,775 shares (a +712.6% increase).  • Hollencrest Capital Management – acquired a new, albeit small, position in ABCL.  • Caitong International Asset Management Co. Ltd – opened a new position.  • Lantern Wealth Advisors LLC – bought a new stake in the stock.  • Marex Group plc – also reported a new position.  • Goldman Sachs Group Inc. – based on recent filings, appears to have increased its ABCL holdings (very large position noted on MarketBeat data) Goldman position is significant! This bodes well for ABCL.
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 14 at 12:30 AM
$ABCL Current Stock Price: $3.11 Contracts to trade: $3.0 ABCL Feb 20 2026 Call Entry: $0.14 Exit: $0.27 ROI: 97% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DragonAlgo
DragonAlgo Feb. 13 at 11:00 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 10:45 PM
$ABCL This won’t hurt. https://x.com/PLTRs_Palantir/status/2022280007255482555?s=20
1 · Reply
SultanK
SultanK Feb. 13 at 8:00 PM
$ABCL https://www.nasdaq.com/market-activity/stocks/abcl/institutional-holdings
0 · Reply
Samb2344
Samb2344 Feb. 13 at 4:20 PM
$ABCL patience
2 · Reply
Rastafari
Rastafari Feb. 13 at 4:01 PM
$ABCL State of Michigan baby!
1 · Reply
danchuga
danchuga Feb. 13 at 3:11 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 2:54 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 12 at 9:11 PM
$ABCL https://x.com/ScrooogeUncle/status/2021967584195674155?s=20
0 · Reply
Latest News on ABCL
AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 3 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 3 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 4 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 5 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 10 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 10 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


Rastafari
Rastafari Feb. 14 at 4:43 PM
$ABCL These reflect institutions that have reported new positions or significant increases in ABCL stock in the latest reporting periods (e.g., Q3 2025 – recent 13F filings): • State of Michigan Retirement System – significantly boosted its stake, reporting ~400,000 shares after adding ~350,775 shares (a +712.6% increase).  • Hollencrest Capital Management – acquired a new, albeit small, position in ABCL.  • Caitong International Asset Management Co. Ltd – opened a new position.  • Lantern Wealth Advisors LLC – bought a new stake in the stock.  • Marex Group plc – also reported a new position.  • Goldman Sachs Group Inc. – based on recent filings, appears to have increased its ABCL holdings (very large position noted on MarketBeat data) Goldman position is significant! This bodes well for ABCL.
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 14 at 12:30 AM
$ABCL Current Stock Price: $3.11 Contracts to trade: $3.0 ABCL Feb 20 2026 Call Entry: $0.14 Exit: $0.27 ROI: 97% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DragonAlgo
DragonAlgo Feb. 13 at 11:00 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 10:45 PM
$ABCL This won’t hurt. https://x.com/PLTRs_Palantir/status/2022280007255482555?s=20
1 · Reply
SultanK
SultanK Feb. 13 at 8:00 PM
$ABCL https://www.nasdaq.com/market-activity/stocks/abcl/institutional-holdings
0 · Reply
Samb2344
Samb2344 Feb. 13 at 4:20 PM
$ABCL patience
2 · Reply
Rastafari
Rastafari Feb. 13 at 4:01 PM
$ABCL State of Michigan baby!
1 · Reply
danchuga
danchuga Feb. 13 at 3:11 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 2:54 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 12 at 9:11 PM
$ABCL https://x.com/ScrooogeUncle/status/2021967584195674155?s=20
0 · Reply
Odoji
Odoji Feb. 12 at 7:47 PM
$ABCL leaving this for the fudders, have a nice weekend all try to do something nice w a loved one 💘💉
1 · Reply
Odoji
Odoji Feb. 12 at 6:01 PM
$ABCL adding a few more and not looking at market till next week 😅
1 · Reply
estatebuyersmia
estatebuyersmia Feb. 12 at 5:52 PM
$ABCL THIS IS A BAD MONTH FOR BIOTECH BUT IT WILL PASS
0 · Reply
Plutten1973
Plutten1973 Feb. 12 at 5:25 PM
$ABCL i always tried to be happy as long as we iver 3 😆😆
1 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 12 at 12:15 AM
$ABCL https://investors.abcellera.com/news/news-releases/2026/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-March-and-April-2026/default.aspx
1 · Reply
8008track
8008track Feb. 11 at 7:37 PM
$ABCL I bought more today.
0 · Reply
raccoonblackbear
raccoonblackbear Feb. 11 at 5:11 PM
$ABCL genuinely shocked at ABCL's strength today
0 · Reply
tradersunion353
tradersunion353 Feb. 11 at 5:08 PM
$ABCL Wgats wrong with this stock I mean tjis can trade at $5 and drop 20% but its almost trading at bottom and still continues to drop Overhyped and underperforming Investors are here to make not just excited about science etc
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 11 at 4:36 PM
$PLTR …”Agnes, this is a most critical period in your life; never have the heavens gathered in such strong configuration. Above all, you must be calm, not hasty, and think things through. On the whole portents are in your favor…provided you avoid ill-considered action.” Robert A. Heinlein. Stranger in a Strange Land. NY: Putnam, 1961, p.80 Continued accumulating $PLTR, $ABCL, $ACHR in small, very small, quantities, every day this week.
1 · Reply
Odoji
Odoji Feb. 11 at 3:11 PM
$ABCL added💉
1 · Reply
Odoji
Odoji Feb. 11 at 2:56 PM
$ABCL I’m a broke degen need the price much lower so I can stack more 🤷‍♂️💉
1 · Reply
tutmose
tutmose Feb. 11 at 8:55 AM
$ABCL Freybentos is spreading fasle information. The company's actual cash burn rate is less than $35 million and at end of 3rd quarter they had $625.6 million in cash and marketable securities. If you add other current assets they had $751.3 million. See their actual balance sheet total assets increased by about $5 million and total liabilities decreased by $87 million. They use their cash for operating expenses, investing in new buildings, equipments and also have non cash write off for depreciation etc.... The pell grant which they received from the Canadian government is listed in their liabilities section and moved to assets section once they are finished with the buildings and equipment is received. It is then moved. This company has zero debt and enough liquidity or cash until at least 2030. Their CEO Carl Hansen is the largest shareholder and he owns about 57 million shares followed by the Baker brothers with 27.5 million shares. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=319559524&type=HTML&symbol=ABCL&companyName=AbCellera+Biologics+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2025-11-06#ic9df010e22cb4881be2664decc3e6028_19
2 · Reply